Physician profile
Leonardo Macias
NPI 1710154315
$14,586.31
in general payments reported to CMS, 2019-2025
19 companies · $769 in 2025
The $769 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,833 · 2020: $274 · 2021: $886 · 2022: $586 · 2023: $1,194 · 2024: $2,044 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,977 · Travel and Lodging: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,977.46 |
| Travel and Lodging | $1,029.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,438.12 | 2019-2025 | |
| Abbott Laboratories | $2,091.19 | 2019-2025 | Mitraclip, 2nd Gen Centrimag Primary Console |
| Abiomed | $1,430.14 | 2019-2024 | Impella |
| Boston Scientific Corporation | $555.81 | 2019-2023 | Watchman Access System |
| Heartflow, INC. | $493.43 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $351.67 | 2021-2025 | Lokelma, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $309.84 | 2019-2024 | Camzyos |
| Cvrx, INC. | $266.32 | 2019-2023 | Barostim Neo System |
| Amgen INC. | $194.47 | 2020-2024 | Repatha |
| Edwards Lifesciences Corporation | $140.39 | 2024 | Pascal |
| Medtronic, INC. | $62.78 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.53 | 2020 | |
| Pfizer INC. | $39.84 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.39 | 2019-2021 | |
| Ge Healthcare | $36.16 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $31.70 | 2025 | Biograph Horizon-3r |
| Medtronic Vascular, INC. | $30.50 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $16.12 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $14.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Macias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.